Recognition of this side effect and discontinuation of the causative drug may prevent angle closure and related vision loss.
📌 3 Key Takeaways
🎯
Objective & Hypothesis:We present a case report of a 26-year-old female patient with acute visual impairment, who had been treated with 50 mg/ day topiramate for 5 days for migraine prophylaxis.
📊
Key Findings & Data:She had no previous ocular pathology, but her cycloplegic refraction showed a myopic shift of about 6 D.
💡
Conclusion & Impact:Recognition of this side effect and discontinuation of the causative drug may prevent angle closure and related vision loss.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters
Abstract
We present a case report of a 26-year-old female patient with acute visual impairment, who had been treated with 50 mg/ day topiramate for 5 days for migraine prophylaxis. Ocular examination showed bilateral anterior chamber narrowing and macular striae. She had no previous ocular pathology, but her cycloplegic refraction showed a myopic shift of about 6 D. Topiramate was stopped and the patient's unaided visual level and macular stria returned to normal with topical steroid and cyclopentolate treatment. Recognition of this side effect and discontinuation of the causative drug may prevent angle closure and related vision loss.
🔖
Cite This Article
DOĞAN, L. (2022). Acute Myopic Shift and Internal Limiting Membrane Folds Linked to Topiramate Use: A Case Report. BEYOGLU EYE JOURNAL, Cilt: 7 - Sayı: 1, 71–74. https://ajindex.com/articles/649045
Ramadan NM, Buchanan TM. New and future migraine therapy. Pharmacol Ther 2006;112:199–212
Fariba K, Saadabadi A. Topiramate. [Updated 2020 Dec 5]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021 Jan-. Available at: https://www.ncbi.nlm.nih.gov/books/ NBK554530/. Accessed Jan 17, 2022
Banta JT, Hoffman K, Budenz DL, Ceballos E, Greenfield DS. Presumed topiramate-induced bilateral acute angle-closure glaucoma. Am J Ophthalmol 2001;132:112–4
Schear NJ, Rowan AJ, Wiener JA, Haug SJ, Mindel JS. Druginduced myopia: a transient side effect of topiramate. Epilepsia 1990;31:643
Koçer AM, Bahar TS, Elgin KU. Topiramata bağlı miyopik kayma ve akut bilateral açı kapanması glokomu. Glokom Katarakt 2019;14:47–50
Orum O, Tarakcioglu H, Yigit U. Topiramate-induced myopic shift and bilateral secondary angle-closure glaucoma. TJO 2012;42:154–6
Kalina PH, Kalina AG. Bilateral transient myopia induced by oral acetazolamide in the early postoperative period after phacoemulsification. JCRS 2020;8:1–3
Craig JE, Ong TJ, Louis DL, Wells JM. Mechanism of topiramate- induced acute-onset myopia and angle closure glaucoma. Am J Ophthalmol 2004;137:193–5
Abtahi MA, Abtahi SH, Fazel F, Roomizadeh P, Etemadifar M, Jenab K, et al. Topiramate and the vision: a systematic review. Clin Ophthalmol 2012;6:117–31
Natesh S, Rajashekhara SK, Rao AS, Shetty B. Topiramate-induced angle closure with acute myopia, macular striae. Oman J Ophthalmol 2010;3:26–8
Gualtieri W, Janula J. Topiramate maculopathy. Int Ophthalmol 2013;33:103–6
Sears N, Modi YS, Engel R, Singh RP. Topiramate-induced myopic shift with associated retinal striae. Can J Ophthalmol 2015;50:e46–50